Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
Journal of Materials Chemistry. B|December 7, 2019
Sustained release of bioactive IGF-1 from a silk fibroin microsphere-based injectable alginate hydrogel for the treatment of myocardial infarctionJianguo Feng, Yong Wu, Weiqian Chen, et al.
Oncology Letters|February 20, 2016
Acute lymphocytic leukemia mimicking spondyloarthritis in an adolescent: A case report and review of the literatureDanyi Xu, Guanhua Xu, Liqin Xu, et al.
Bioengineering & Translational Medicine|May 19, 2023
An immunometabolic patch facilitates mesenchymal stromal/stem cell therapy for myocardial infarction through a macrophage-dependent mechanismWeizhang Xiao, Ming Chen, Wenjing Zhou, et al.
Stem Cell Research & Therapy|November 28, 2017
MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarctionYueqiu Chen, Yunfeng Zhao, Weiqian Chen, et al.
Oncotargets and Therapy|March 11, 2017
125I brachytherapy of locally advanced non-small-cell lung cancer after one cycle of first-line chemotherapy: a comparison with best supportive careJingjing Song, Xiaoxi Fan, Zhongwei Zhao, et al.
Bioactive Materials|September 30, 2020
Release of VEGF and BMP9 from injectable alginate based composite hydrogel for treatment of myocardial infarctionYong Wu, Tianqi Chang, Weiqian Chen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 1, 2025
CTLA-4 nanovesicles disrupt dendritic cell-driven CD8 T cell priming for myocardial infarction therapyShengnan Wang, Mengting Li, Han Shen, et al.
Regenerative Biomaterials|January 15, 2024
Precision cardiac targeting: empowering curcumin therapy through smart exosome-mediated drug delivery in myocardial infarctionMing Chen, Shengnan Wang, Yihuan Chen, et al.
Oncotarget|February 27, 2016
Selective killing of gastric cancer cells by a small molecule via targeting TrxR1 and ROS-mediated ER stress activationWeiqian Chen, Peng Zou, Zhongwei Zhao, et al.
Frontiers in Molecular Biosciences|February 1, 2021
Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective StudyLiyun Zheng, Shiji Fang, Fazong Wu, et al.
Pageof 14